argenx FB102 meets Phase 2 endpoint
argenx (NASDAQ:ARGX) said its Phase 2 study of FB102 in adults with celiac disease met its primary endpoint, showing a statistically significant improvement versus placebo at day 78 with a p-value of 0.0176.

Jon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.
argenx (NASDAQ:ARGX) said its Phase 2 study of FB102 in adults with celiac disease met its primary endpoint, showing a statistically significant improvement versus placebo at day 78 with a p-value of 0.0176.
OzCar has entered voluntary administration after secured creditors appointed administrators to assess the company's financial options.
Yandal Resources (ASX:YRL) has commenced a seven-hole, 3,300-metre diamond drilling programme to test high-grade gold mineralisation at depth at its Arrakis prospect.
Cazaly Resources (ASX:CAZ) has commenced reverse circulation drilling at its Gulls Blow gold prospect located 90km north of Kalgoorlie.
NOVONIX (ASX:NVX) has achieved ISO 9001:2015 certification following an independent audit of its quality management system.
REA Group (ASX:REA) recorded a 2% drop in national property listings during the first quarter of the 2027 financial year.
Lucas GC (NASDAQ:LGCL) reported its first-half financial results for the period ended June 30, 2026, generating total revenue of $35.74 million (RMB245.3 million).
BD (NYSE:BDX) announced nine-month AGILITY trial results showing its Revello Vascular Covered Stent met the primary endpoint with a 97.2% primary patency rate in iliac artery disease.
Gilat Satellite Networks (NASDAQ:GILT) secured over $10 million in additional SkyEdge IV platform orders to expand high-capacity network connectivity.
SFL Corporation (NYSE:SFL) agreed to sell seven tanker vessels to Trafigura for approximately $275 million in net cash proceeds.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy